Yannick B.
- Country
- France
- Department
- Service de Neurologie Générale, Vasculaire et Dégénérative
Research Overview
- Efficacy of Diroximel Fumarate in Reducing Perihaematomal Oedema in Patients with Spontaneous Intracerebral Haemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial
- Tenecteplase plus Thrombectomy versus Thrombectomy Alone in Patients with Large Core Ischemic Stroke: A Multicentre Randomized Controlled Trial
- Efficacy of prophylactic levetiracetam on functional outcomes in patients with acute intracerebral haemorrhage: a phase 3, randomised, double-blind, placebo-controlled trial
Data & Insights
Has run more than one trial at 187 of 718 partner sites.
Specializations
Cerebrovascular Disorders
This investigator specializes in the treatment and management of acute stroke conditions, with particular emphasis on intracerebral hemorrhage and ischemic stroke interventions.
- Hemorrhagic Stroke Management
- Acute Stroke Treatment
- Prevention Strategies
Their research extends to innovative therapeutic approaches for improving outcomes in acute cerebrovascular events.
Cardiovascular Medicine
The investigator focuses on cardiovascular disease management, particularly studying interventions for atherosclerosis and coronary syndromes.
- Vascular Event Prevention
- Atherosclerotic Disease
- Myocardial Infarction Care
Their work encompasses comprehensive approaches to preventing recurrent major vascular events.
Preventive Neurology
The investigator specializes in stroke prevention strategies, with particular attention to transient ischemic attacks and non-cardioembolic ischemic events.
- Post-Stroke Care
- Secondary Prevention
- Antithrombotic Therapy
Their research focuses on innovative therapeutic approaches for preventing recurrent strokes in high-risk patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.